Scott Hunter, chief commercial officer of Neurotech, passed away on December 3, the company reported this week. Mr. Hunter spent more than two decades in eye care, working in rare disease and specialty markets.

“The entire Neurotech family mourns this loss,” the company said in a statement. “Scott joined Neurotech in January of 2023, and brought his remarkable passion, experience, and energy to the company. He was an exceptional partner and instrumental in building the commercial strategy and infrastructure. Scott loved his family, friends, sports. On behalf of the board of directors, management team, and employees, we extend our deepest sympathies to Scott’s family. He will be deeply missed.”

Prior to joining Neurotech, Mr. Hunter had worked at Novartis, Shire, and Bausch + Lomb. He had earned a master’s degree in pharmacoeconomics from the University of Florida as well as a master of business administration (MBA) from the University of Tampa.